Nurse Practitioner · Coral Gables, FL
NPI
1639425630
Since 2012
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
5101 SW 8th Street, Suite 200
Coral Gables, FL, 33134
Phone (305) 262-6060
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
153 services
Medicare patients, 2024
86
Average age 71
Drug cost, 2024
$2.7M
4,469 prescriptions
Company payments, 2025
$1,480
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jorge Gil was code 99214 (office e&m - established), 134 times for 74 patients. In total Jorge Gil billed 153 services in 4 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 134 | 74 | $80.74 | $11K |
| 99204 Office E&M - New | Office | 12 | 12 | $70.38 | $845 |
By year: 2022 $18K for 208 services; 2023 $13K for 148 services; 2024 $12K for 153 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jorge Gil prescribed most often to Medicare patients was Pantoprazole Sodium, with 983 prescriptions and refills. In total Jorge Gil wrote 4,469 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 983 | 2,576 | 449 | $8,559 |
| Famotidine Generic | 869 | 2,104 | 343 | $16K |
| Dicyclomine Hcl Generic | 538 | 1,077 | 266 | $8,638 |
| Sucralfate Generic | 245 | 566 | 98 | $14K |
| Omeprazole Generic | 232 | 556 | 124 | $2,938 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 132 | 132 | 129 | $8,135 |
| Linzess Linaclotide | 116 | 210 | 45 | $113K |
| Dexlansoprazole Dr Dexlansoprazole | 107 | 245 | 41 | $24K |
| Cholestyramine Cholestyramine (With Sugar) | 101 | 181 | 49 | $13K |
| Zenpep Lipase/Protease/Amylase | 77 | 103 | 18 | $385K |
| Creon Lipase/Protease/Amylase | 75 | 106 | 21 | $300K |
| Hydrocortisone Generic | 67 | 67 | 37 | $999 |
| Mesalamine Generic | 57 | 121 | 18 | $28K |
| Hyoscyamine Sulfate Generic | 56 | 87 | 27 | $1,824 |
| Humira(Cf) Pen Adalimumab | 40 | 40 | Under 11 | $446K |
Brand drugs: 690 claims; generic drugs: 3,723 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jorge Gil $1,480 ($1,480 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $258.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $258 |
| Madrigal Pharmaceuticals MDGL | 9 | $199 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 14 | $163 |
| Novo Nordisk Inc NVO | 3 | $161 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $102 |
| Pfizer Inc. PFE | 6 | $95.72 |
| Janssen Biotech, Inc. JNJ | 5 | $94.18 |
| Ardelyx, Inc. ARDX | 5 | $84.24 |
| Intercept Pharmaceuticals, Inc. | 3 | $74.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.